"Non-alcoholic steatohepatitis (NASH) is a serious, progressive form of non-alcoholic fatty liver disease (NAFLD). NASH is expected to be the leading cause of liver transplants within the next decade. Pfizer researchers are working to develop treatments for NASH and its complications to fill the existing significant unmet medical need.
"
Comments:
No comments yet... Be the first!
Post your comment:
Your comment has been sent and is waiting for approval to be displayed.
Your comment cannot be sent. Please try again.
"WebsEdge was a great team to work with. They covered our 101st Annual Meeting and did a great job at capturing the message we wanted to convey to our attendees. Seemless process prior, during and after the meeting."